Piramal Pharma Receives 67.1 ESG Leader Rating

Key Development

On September 17, 2026, Piramal Pharma Limited received communication from BSE Limited regarding an Environment, Social and Governance (ESG) Rating assigned to the company by Niche Ninety Nine Capability and Certifications (OPC) Private Limited ("Niche99").

Rating Details

• Assigned ESG Rating: 67.1
• ESG Band Classification: Leader

Important Qualifications

• The company has not engaged Niche99 for this ESG rating assignment.
• Niche99 prepared the rating report independently using information available in the public domain.

Purpose and Impact

This disclosure is submitted for informational purposes and record-keeping with the stock exchanges. The company has not quantified any financial impact resulting from this ESG rating assignment.